These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 36633239)

  • 21. Tadalafil Improves Symptoms, Erectile Function and Quality of Life in Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (KYU-PRO Study).
    Takahashi R; Miyazato M; Nishii H; Sumino Y; Takayama K; Onzuka M; Oshiro T; Saito S; Fujimoto N; Mimata H; Eto M
    Low Urin Tract Symptoms; 2018 Jan; 10(1):76-83. PubMed ID: 29341501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical observation on electroacupuncture combined with moxibustion for treatment of urinary incontinence after stroke due to deficiency of kidney-
    Jiang C; Lu LN
    Zhen Ci Yan Jiu; 2020 Jul; 45(7):578-82. PubMed ID: 32705834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of nocturia in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and the analysis of the curative effect after medical or placebo therapy for nocturia: a randomized placebo-controlled study.
    Xue Z; Lin Y; Jiang Y; Wei N; Bi J
    BMC Urol; 2018 Dec; 18(1):115. PubMed ID: 30545338
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical observation of filiform fire needling on moderate and severe pain in advanced cancer].
    Gao X; Zhang SN
    Zhongguo Zhen Jiu; 2020 Jun; 40(6):601-4. PubMed ID: 32538009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Combination therapy of Xipayimaizipizi Capsules and Tamsulosin for benign prostatic hyperplasia].
    Wang J; Xiao Y; Wang ZG; Wang FF; Cui XJ
    Zhonghua Nan Ke Xue; 2015 Nov; 21(11):1005-9. PubMed ID: 26738328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and safety of oral Tamsulosin controlled absorption system (OCAS) for the treatment of lower urinary tract symptoms due to bladder outlet obstruction associated with benign prostatic hyperplasia: an open-label preliminary study.
    Lojanapiwat B; Permpongkosol S
    Int Braz J Urol; 2011; 37(4):468-76. PubMed ID: 21888698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of PKRP and TUVP in the treatment of high-risk BPH and analysis of postoperative influencing factors.
    Song Y; Pang S; Luo G; Li S; He Y; Yang J
    Front Surg; 2022; 9():947027. PubMed ID: 35990094
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate Artery Embolization for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Results From a Prospective FDA-Approved Investigational Device Exemption Study.
    Salem R; Hairston J; Hohlastos E; Riaz A; Kallini J; Gabr A; Ali R; Jenkins K; Karp J; Desai K; Thornburg B; Casalino D; Miller F; Hofer M; Hamoui N; Mouli S
    Urology; 2018 Oct; 120():205-210. PubMed ID: 30036614
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of electroacupuncture in treating 93 patients with benign prostatic hyperplasia].
    Yang T; Zhang XQ; Feng YW
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Nov; 28(11):998-1000. PubMed ID: 19213342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tamsulosin efficiency in treatment of benign prostatic hyperplasia evaluated by determining bladder weight.
    Milicevic S
    Med Arch; 2012; 66(6):391-5. PubMed ID: 23409519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy observation on benign prostatic hyperplasia treated with acupuncture and moxibustion].
    Xu ZJ
    Zhongguo Zhen Jiu; 2014 Mar; 34(3):241-4. PubMed ID: 24843963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparative randomized prospective study to evaluate efficacy and safety of combination of tamsulosin and tadalafil vs. tamsulosin or tadalafil alone in patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Singh DV; Mete UK; Mandal AK; Singh SK
    J Sex Med; 2014 Jan; 11(1):187-96. PubMed ID: 24165272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study of Eviprostat for the treatment of benign prostatic hyperplasia].
    Song Y; Li NC; Wang XF; Ma LL; Wan B; Hong BF; Na YQ
    Zhonghua Nan Ke Xue; 2005 Sep; 11(9):674-6. PubMed ID: 16209208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Body Mass Index and Risk of Prostate Volume, International Prostate Symptom Score, Maximum Urinary Flow Rate, and Post-Void Residual in Benign Prostatic Hyperplasia Patients.
    Li BH; Deng T; Huang Q; Zi H; Weng H; Zeng XT
    Am J Mens Health; 2019; 13(4):1557988319870382. PubMed ID: 31426706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prostatic arterial embolization for benign prostatic hyperplasia in high-risk aged males].
    Yan WH; Zhang C; Al GP; Shu Y
    Zhonghua Nan Ke Xue; 2015 Oct; 21(10):900-3. PubMed ID: 26665678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.
    Porst H; Roehrborn CG; Secrest RJ; Esler A; Viktrup L
    J Sex Med; 2013 Aug; 10(8):2044-52. PubMed ID: 23782459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combined analysis of double-blind trials of the efficacy and tolerability of doxazosin-gastrointestinal therapeutic system, doxazosin standard and placebo in patients with benign prostatic hyperplasia.
    Kirby RS; Andersen M; Gratzke P; Dahlstrand C; Høye K
    BJU Int; 2001 Feb; 87(3):192-200. PubMed ID: 11167641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised, placebo-controlled study to assess the efficacy of twice-daily vardenafil in the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia.
    Stief CG; Porst H; Neuser D; Beneke M; Ulbrich E
    Eur Urol; 2008 Jun; 53(6):1236-44. PubMed ID: 18281145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of precise nursing service mode on postoperative urinary incontinence prevention in patients with prostate disease.
    Zheng XC; Luo TT; Cao DD; Cai WZ
    World J Clin Cases; 2022 Feb; 10(5):1517-1526. PubMed ID: 35211589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomised, placebo-controlled, multicentre, Phase 2 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia.
    Moon KT; Yoo TK; Kwon SY; Ha JY; Byun SS; Kim JH; Chung JI; Kim TH; Moon HS; Kim SJ; Lee KS
    BJU Int; 2018 Aug; 122(2):283-292. PubMed ID: 29633507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.